ProQinase GmbH was founded in 2001 as a subsidiary of the Tumor Biology Center Freiburg. This cancer center combined excellent research with exceptional patient care under one roof. Initially, ProQinase was established in order to support funding of the Tumor Biology Center´s in-house anti-cancer drug development by marketing research tools and test systems. Today, ProQinase is a leading contract research organization (CRO) for drug discovery in oncology.
Since 2015 ProQinase belongs to a Chinese private equity fund. The company has about 40 employees and is located in Freiburg in the south-west of Germany. The labs and offices in Freiburg are complemented by a storage site in the Boston area, USA.
Our vision is to develop the company into a world class CRO for Integrated Drug Discovery (IDD) in oncology.